Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma

Methods in Molecular Biology

Volumn 909, Issue , 2012, Pages 295-310

  Wong, Kwong Fai ^a   Luk, John M ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Circulating biomarker in blood; Early diagnosis; Hepatocellular carcinoma; Lamin B1; Proteomics; Vimentin

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; LAMIN B; LAMIN B1; MESSENGER RNA; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL INFORMATICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84934440538     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-959-4_19     Document Type: Article

References (79)

1. Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, Poon RT (2009) Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9:389
2. Spangenberg HC, Thimme R, Blum HE (2009) Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 6: 423-432
3. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008) Gene expression in fixed tissues and outcome in hepatocel-lular carcinoma. N Engl J Med 359:1995-2004
4. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J (2001) Genetic alterations associated with hepatocel-lular carcinomas de fine distinct pathways of hepatocarcinogenesis. Gastroenterology 120:1763-1773
5. Kaposi-Novak P, Libbrecht L, Woo HG, Lee Y-H, Sears NC, Coulouarn C, Conner EA, Factor VM, Roskams T, Thorgeirsson SS (2009) Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 69:2775-2782
6. Wang SM, Ooi LLPJ, Hui KM (2007) Identi fication and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res 13:6275-6283
7. Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM (2010) microRNA-122 as a regulator of mitochondrial metabolic gene network in hepato-cellular carcinoma. Mol Syst Biol 6:402
8. Sun S, Yi X, Poon RT, Yeung C, Day PJ, Luk JM (2009) A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. BMC Cancer 9:309
9. Sun S, Day PJ, Lee NP, Luk JM (2009) Biomarkers for early detection of liver cancer: focus on clinical evaluation. Protein Pept Lett 16:473-478
10. Sun S, Lee NP, Poon RT, Fan ST, He QY, Lau GK, Luk JM (2007) Oncoproteomics of hepa-tocellular carcinoma: from cancer markers' discovery to functional pathways. Liver Int 27: 1021-1038
11. Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, Peng J, Leng X, Day PJ, Fan ST (2007) Arti ficial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun 361:68-73
12. Luk JM, Su YC, Lam SC, Lee CK, Hu MY, He QY, Lau GK, Wong FW, Fan ST (2005) Proteomic identi fication of Ku70/Ku80 autoan-tigen recognized by monoclonal antibody against hepatocellular carcinoma. Proteomics 5:1980-1986
13. Lee NP, Leung KW, Cheung N, Lam BY, Xu MZ, Sham PC, Lau GK, Poon RT, Fan ST, Luk JM (2008) Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocel-lular carcinoma. Proteomics 8:2136-2149
14. Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM (2009) Proteomic expression signature distinguishes cancerous and nonma-lignant tissues in hepatocellular carcinoma. J Proteome Res 8:1293-1303
15. Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM, Fan ST (2006) Proteomic pro filing of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6:1049-1057
16. Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST (2008) Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 7:315-325
17. Lu WJ, Lee NP, Fatima S, Luk JM (2009) Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Protein Pept Lett 16:508-516
18. Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, Luk JM (2011) Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int J Cancer 129: 1806-1814.
19. Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, Luk JM (2011) Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ 18:1046-1056
20. Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM (2010) Enhanced detection of early hepatocel-lular carcinoma by serum SELDI-TOF pro-teomic signature combined with alpha-fetoprotein marker. Ann Surg Oncol 17:2518-2525
21. Fukuda S, Itamoto T, Nakahara H, Kohashi T, Ohdan H, Hino H, Ochi M, Tashiro H, Asahara T (2005) Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 52:1163-1167
22. Kikuchi LO, Paranagua-Vezozzo DC, Chagas AL, Mello ES, Alves VA, Farias AQ, Pietrobon R, Carrilho FJ (2009) Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J Clin Gastroenterol 43:191-195
23. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138:493-502
24. Kim MJ (2011) Current limitations and potential breakthroughs for the early diagnosis of hepatocellular carcinoma. Gut Liver 5:15-21
25. Sun S, Poon RT, Lee NP, Yeung C, Chan KL, Ng IO, Day PJ, Luk JM (2010) Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (
26. Sun S, Xu MZ, Poon RT, Day PJ, Luk JM (2010) Circulating lamin B1 (LMNB1) bio-marker detects early stages of liver cancer in patients. J Proteome Res 9:70-78
27. Hu MY, Lam CT, Liu KD, Xu Z, Fatima S, Su YC, Tsang F, Chen J, Pang JZ, Qin LX, Luk JM (2009) Proteomic identi fication of a monoclonal antibody recognizing caveolin-1 in hepatocellular carcinoma with metastatic potential. Protein Pept Lett 16:479-485
28. Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C, Mao M, Dai H, Wang XL, Xu MZ, Lee TK, Ng IO, Chen Y, Kung HF, Lowe SW, Poon RT, Wang JH, Luk JM (2009) Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50:1453-1463
29. Luk JM, Wong KF (2006) Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma. Clin Exp Pharmacol Physiol 33:482-488
30. Tsang FH, Lee NP, Luk JM (2009) The use of small peptides in the diagnosis and treatment of hepatocellular carcinoma. Protein Pept Lett 16:530-538
31. Speers AE, Wu CC (2007) Proteomics of integral membrane proteins-theory and application. Chem Rev 107:3687-3714
32. Josic D, Clifton JG (2007) Mammalian plasma membrane proteomics. Proteomics 7:3010-3029
33. Rabilloud T, Adessi C, Giraudel A, Lunardi J (1997) Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 18:307-316
34. James GT (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal Biochem 86:574-579
35. Xu MZ, Chan SW, Liu AM, Wong KF, Fan ST, Chen J, Poon RT, Zender L, Lowe SW, Hong W, Luk JM (2010) AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30:1229-1240
36. Wong KF, Luk JM, Cheng RH, Klickstein LB, Fan ST (2007) Characterization of two novel LPS-binding sites in leukocyte integrin betaA domain. FASEB J 21:3231-3239
37. Li C, Hong Y, Tan YX, Zhou H, Ai JH, Li SJ, Zhang L, Xia QC, Wu JR, Wang HY, Zeng R (2004) Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded af finity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics 3:399-409
38. Ai J, Tan Y, Ying W, Hong Y, Liu S, Wu M, Qian X, Wang H (2006) Proteome analysis of hepatocellular carcinoma by laser capture microdissection. Proteomics 6:538-546
39. Guedj N, Dargere D, Degos F, Janneau JL, Vidaud D, Belghiti J, Bedossa P, Paradis V (2006) Global proteomic analysis of microdis-sected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. Lab Invest 86:951-958
40. Chan JK, Thompson JW, Gill TA (1995) Quantitative determination of protamines by coomassie blue G assay. Anal Biochem 226:191-193
41. Nassiri M, Ramos S, Zohourian H, Vincek V, Morales AR, Nadji M (2008) Preservation of biomolecules in breast cancer tissue by a formalin-free histology system. BMC Clin Pathol 8:1
42. Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF III, Liotta LA (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7:1998-2018
43. Rountree CB, Van Kirk CA, You H, Ding W, Dang H, Vanguilder HD, Freeman WM (2010) Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization. Proteome Sci 8:61
44. Svensson M, Boren M, Skold K, Falth M, Sjogren B, Andersson M, Svenningsson P, Andren PE (2009) Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res 8:974-981
45. Goodwin RJ, Lang AM, Allingham H, Boren M, Pitt AR (2010) Stopping the clock on proteomic degradation by heat treatment at the point of tissue excision. Proteomics 10:1751-1761
46. Robinson AA, Westbrook JA, English JA, Boren M, Dunn MJ (2009) Assessing the use of thermal treatment to preserve the intact pro-teomes of post-mortem heart and brain tissue. Proteomics 9:4433-4444
47. Scholz B, Skold K, Kultima K, Fernandez C, Waldemarson S, Savitski MM, Svensson M, Boren M, Stella R, Andren PE, Zubarev R, James P (2011) Impact of temperature dependent sampling procedures in proteomics and peptidomics-a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics 10:M900229MCP200
48. Rossbach U, Nilsson A, Falth M, Kultima K, Zhou Q, Hallberg M, Gordh T, Andren PE, Nyberg F (2009) A quantitative peptidomic analysis of peptides related to the endogenous opioid and tachykinin systems in nucleus accumbens of rats following naloxone-precipi-tated morphine withdrawal. J Proteome Res 8:1091-1098
49. Qian WJ, Jacobs JM, Liu T, Camp DG II, Smith RD (2006) Advances and challenges in liquid chromatography-mass spectrometry-based proteomics pro filing for clinical applications. Mol Cell Proteomics 5:1727-1744
50. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971-983
51. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
52. Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL, Steiner S (2003) Multi-component immunoaf finity subtraction chro-matography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3:422-432
53. Brand J, Haslberger T, Zolg W, Pestlin G, Palme S (2006) Depletion ef ficiency and recovery of trace markers from a multiparameter immu-nodepletion column. Proteomics 6:3236-3242
54. Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, Zhang X, Mottaz HM, Varnum SM, Camp DG II, Huang L, Fang X, Zhang WW, Smith RD (2008) Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaf finity separation strategy. Mol Cell Proteomics 7:1963-1973
55. Zhang H, Li XJ, Martin DB, Aebersold R (2003) Identi fication and quanti fication of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spec-trometry. Nat Biotechnol 21:660-666
56. Liu T, Qian WJ, Strittmatter EF, Camp DG II, Anderson GA, Thrall BD, Smith RD (2004) High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem 76:5345-5353
57. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J (2005) Standardized approach to proteome pro filing of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 51:973-980
58. Zhang L, Xie J, Wang X, Liu X, Tang X, Cao R, Hu W, Nie S, Fan C, Liang S (2005) Proteomic analysis of mouse liver plasma membrane: use of differential extraction to enrich hydrophobic membrane proteins. Proteomics 5:4510-4524
59. Everberg H, Peterson R, Rak S, Tjerneld F, Emanuelsson C (2006) Aqueous two-phase partitioning for proteomic monitoring of cell surface biomarkers in human peripheral blood mononuclear cells. J Proteome Res 5: 1168-1175
60. Kohnke PL, Mulligan SP, Christopherson RI (2009) Membrane proteomics for leukemia classi fication and drug target identi fication. Curr Opin Mol Ther 11:603-610
61. Rahbar AM, Fenselau C (2004) Integration of Jacobson's pellicle method into proteomic strategies for plasma membrane proteins. J Proteome Res 3:1267-1277
62. Zhang LJ, Wang XE, Peng X, Wei YJ, Cao R, Liu Z, Xiong JX, Yin XF, Ping C, Liang S (2006) Proteomic analysis of low-abundant integral plasma membrane proteins based on gels. Cell Mol Life Sci 63:1790-1804
63. Macher BA, Yen TY (2007) Proteins at membrane surfaces-a review of approaches. Mol Biosyst 3:705-713
64. Stasyk T, Huber LA (2004) Zooming in: frac-tionation strategies in proteomics. Proteomics 4:3704-3716
65. Tang X, Yi W, Munske GR, Adhikari DP, Zakharova NL, Bruce JE (2007) Pro filing the membrane proteome of Shewanella oneidensis MR-1 with new af finity labeling probes. J Proteome Res 6:724-734
66. Scheurer SB, Rybak JN, Roesli C, Brunisholz RA, Potthast F, Schlapbach R, Neri D, Elia G (2005) Identi fication and relative quanti fication of membrane proteins by surface biotinylation and two-dimensional peptide mapping. Proteomics 5:2718-2728
67. Rybak JN, Ettorre A, Kaissling B, Giavazzi R, Neri D, Elia G (2005) In vivo protein biotiny-lation for identi fication of organ-speci fic antigens accessible from the vasculature. Nat Methods 2:291-298
68. Lu B, McClatchy DB, Kim JY, Yates JR III (2008) Strategies for shotgun identi fication of integral membrane proteins by tandem mass spectrometry. Proteomics 8:3947-3955
69. Na K, Lee EY, Lee HJ, Kim KY, Lee H, Jeong SK, Jeong AS, Cho SY, Kim SA, Song SY, Kim KS, Cho SW, Kim H, Paik YK (2009) Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 9:3989-3999
70. Chaerkady R, Thuluvath PJ, Kim MS, Nalli A, Vivekanandan P, Simmers J, Torbenson M, Pandey A (2008) O Labeling for a quantitative proteomic analysis of glycoproteins in hepatocellular carcinoma. Clin Proteomics 4: 137-155
71. Dai Z, Fan J, Liu Y, Zhou J, Bai D, Tan C, Guo K, Zhang Y, Zhao Y, Yang P (2007) Identi fication and analysis of alpha1, 6-fucosy-lated proteins in human normal liver tissues by a target glycoproteomic approach. Electrophoresis 28:4382-4391
72. Xu Z, Zhou X, Lu H, Wu N, Zhao H, Zhang L, Zhang W, Liang YL, Wang L, Liu Y, Yang P, Zha X (2007) Comparative glycoproteomics based on lectins af finity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells. Proteomics 7:2358-2370
73. Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, Aebersold R, Watts JD (2009) Mass-spectrometric identi fication and relative quanti fication of N-linked cell surface glycoproteins. Nat Biotechnol 27:378-386
74. Cottingham K (2008) Antibodypedia seeks to answer the question: "how good is that antibody?". J Proteome Res 7:4213
75. Bjorling E, Uhlen M (2008) Antibodypedia, a portal for sharing antibody and antigen validation data. Mol Cell Proteomics 7:2028-2037
76. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
77. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
78. Peterson GL (1979) Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal Biochem 100:201-220
79. Stoscheck CM (1990) Quantitation of protein. Methods Enzymol 182:50-68